These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients. Strippoli GF, Tong A, Palmer SC, Elder G, Craig JC. Cochrane Database Syst Rev; 2006 Oct 18; (4):CD006254. PubMed ID: 17054287 [Abstract] [Full Text] [Related]
8. Association of Drug Effects on Serum Parathyroid Hormone, Phosphorus, and Calcium Levels With Mortality in CKD: A Meta-analysis. Palmer SC, Teixeira-Pinto A, Saglimbene V, Craig JC, Macaskill P, Tonelli M, de Berardis G, Ruospo M, Strippoli GF. Am J Kidney Dis; 2015 Dec 18; 66(6):962-71. PubMed ID: 26003472 [Abstract] [Full Text] [Related]
9. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)]. Lorenzo Sellares V, Torregrosa V. Nefrologia; 2008 Dec 18; 28 Suppl 3():67-78. PubMed ID: 19018742 [Abstract] [Full Text] [Related]
17. Mortality risk among hemodialysis patients receiving different vitamin D analogs. Tentori F, Hunt WC, Stidley CA, Rohrscheib MR, Bedrick EJ, Meyer KB, Johnson HK, Zager PG, Medical Directors of Dialysis Clinic Inc. Kidney Int; 2006 Nov 08; 70(10):1858-65. PubMed ID: 17021609 [Abstract] [Full Text] [Related]
18. Cinacalcet plus vitamin D versus vitamin D alone for the treatment of secondary hyperparathyroidism in patients undergoing dialysis: a meta-analysis of randomized controlled trials. Xu J, Yang Y, Ma L, Fu P, Peng H. Int Urol Nephrol; 2019 Nov 08; 51(11):2027-2036. PubMed ID: 31531805 [Abstract] [Full Text] [Related]
20. Control of parathyroid function in patients with a short history of hemodialysis. Nishi H, Sato T, Kurihara T, Kurosawa T, Fukagawa M. Ther Apher Dial; 2005 Feb 08; 9(1):39-43. PubMed ID: 15828904 [Abstract] [Full Text] [Related] Page: [Next] [New Search]